Efficacy of telemedicine for stroke: Pooled analysis of the stroke team remote evaluation using a digital observation camera (STRokE DOC) and STRokE DOC Arizona telestroke trials

Bart M Demaerschalk, Rema Raman, Karin Ernstrom, Brett C. Meyer

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Background and Purpose: Telemedicine can disseminate vascular neurology expertise and optimize recombinant tissue plasminogen activator (rt-PA) use for acute ischemic stroke in rural underserved communities. The purpose of this study was to prospectively assess whether telemedicine or telephone was superior for decision-making. Methods: The study design is a pooled analysis of two identically designed randomized controlled trials conducted in a multistate hub and spoke telestroke network setting with acute stroke syndrome patients, comparing telemedicine versus telephone-only consultations. From each trial, common data elements were pooled to assess, principally, for correctness of thrombolysis decision-making. Secondary outcomes included rt-PA use rate, 90-day functional outcome, post-thrombolysis intracranial hemorrhage, and data completeness. Results: Two hundred seventy-six pooled patients were evaluated. Correct thrombolysis eligibility decisions were made more often with telemedicine (96% telemedicine, 83% telephone; odds ratio [OR] 4.2; 95% confidence interval [CI] 1.69-10.46; p=0.002). Intravenous rt-PA usage was 26% (29% telemedicine, 24% telephone; OR 1.27; 95% CI 0.71-2.25; p=0.41). Ninety-day outcomes were not different for Barthel Index, modified Rankin Scale, or mortality. There was no difference in post-thrombolysis intracranial hemorrhage (8% telemedicine, 6% telephone; p>0.999). Conclusions: This pooled analysis supports the hypothesis that stroke telemedicine consultations, compared with telephone-only, result in more accurate decision-making. Together with high rt-PA utilization rate, low post-rt-PA intracranial hemorrhage rate, and acceptable patient outcome, the results confirm that telemedicine is a viable consultative tool for acute stroke. The replication of the hub and spoke network infrastructure supports the generalizability of telemedicine when used in broader settings.

Original languageEnglish (US)
Pages (from-to)230-237
Number of pages8
JournalTelemedicine and e-Health
Volume18
Issue number3
DOIs
StatePublished - Apr 1 2012

Fingerprint

Telemedicine
Stroke
Observation
Telephone
Tissue Plasminogen Activator
Intracranial Hemorrhages
Decision Making
Referral and Consultation
Odds Ratio
Confidence Intervals
Rural Population
Neurology
Blood Vessels
Randomized Controlled Trials
Mortality

Keywords

  • randomized controlled trials
  • rural health
  • rural hospitals
  • stroke
  • telemedicine
  • telestroke
  • tissue plasminogen activator

ASJC Scopus subject areas

  • Medicine(all)
  • Health Informatics
  • Health Information Management

Cite this

@article{d14e2460f54448258f8032ba5c03831e,
title = "Efficacy of telemedicine for stroke: Pooled analysis of the stroke team remote evaluation using a digital observation camera (STRokE DOC) and STRokE DOC Arizona telestroke trials",
abstract = "Background and Purpose: Telemedicine can disseminate vascular neurology expertise and optimize recombinant tissue plasminogen activator (rt-PA) use for acute ischemic stroke in rural underserved communities. The purpose of this study was to prospectively assess whether telemedicine or telephone was superior for decision-making. Methods: The study design is a pooled analysis of two identically designed randomized controlled trials conducted in a multistate hub and spoke telestroke network setting with acute stroke syndrome patients, comparing telemedicine versus telephone-only consultations. From each trial, common data elements were pooled to assess, principally, for correctness of thrombolysis decision-making. Secondary outcomes included rt-PA use rate, 90-day functional outcome, post-thrombolysis intracranial hemorrhage, and data completeness. Results: Two hundred seventy-six pooled patients were evaluated. Correct thrombolysis eligibility decisions were made more often with telemedicine (96{\%} telemedicine, 83{\%} telephone; odds ratio [OR] 4.2; 95{\%} confidence interval [CI] 1.69-10.46; p=0.002). Intravenous rt-PA usage was 26{\%} (29{\%} telemedicine, 24{\%} telephone; OR 1.27; 95{\%} CI 0.71-2.25; p=0.41). Ninety-day outcomes were not different for Barthel Index, modified Rankin Scale, or mortality. There was no difference in post-thrombolysis intracranial hemorrhage (8{\%} telemedicine, 6{\%} telephone; p>0.999). Conclusions: This pooled analysis supports the hypothesis that stroke telemedicine consultations, compared with telephone-only, result in more accurate decision-making. Together with high rt-PA utilization rate, low post-rt-PA intracranial hemorrhage rate, and acceptable patient outcome, the results confirm that telemedicine is a viable consultative tool for acute stroke. The replication of the hub and spoke network infrastructure supports the generalizability of telemedicine when used in broader settings.",
keywords = "randomized controlled trials, rural health, rural hospitals, stroke, telemedicine, telestroke, tissue plasminogen activator",
author = "Demaerschalk, {Bart M} and Rema Raman and Karin Ernstrom and Meyer, {Brett C.}",
year = "2012",
month = "4",
day = "1",
doi = "10.1089/tmj.2011.0116",
language = "English (US)",
volume = "18",
pages = "230--237",
journal = "Telemedicine Journal and e-Health",
issn = "1530-5627",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Efficacy of telemedicine for stroke

T2 - Pooled analysis of the stroke team remote evaluation using a digital observation camera (STRokE DOC) and STRokE DOC Arizona telestroke trials

AU - Demaerschalk, Bart M

AU - Raman, Rema

AU - Ernstrom, Karin

AU - Meyer, Brett C.

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Background and Purpose: Telemedicine can disseminate vascular neurology expertise and optimize recombinant tissue plasminogen activator (rt-PA) use for acute ischemic stroke in rural underserved communities. The purpose of this study was to prospectively assess whether telemedicine or telephone was superior for decision-making. Methods: The study design is a pooled analysis of two identically designed randomized controlled trials conducted in a multistate hub and spoke telestroke network setting with acute stroke syndrome patients, comparing telemedicine versus telephone-only consultations. From each trial, common data elements were pooled to assess, principally, for correctness of thrombolysis decision-making. Secondary outcomes included rt-PA use rate, 90-day functional outcome, post-thrombolysis intracranial hemorrhage, and data completeness. Results: Two hundred seventy-six pooled patients were evaluated. Correct thrombolysis eligibility decisions were made more often with telemedicine (96% telemedicine, 83% telephone; odds ratio [OR] 4.2; 95% confidence interval [CI] 1.69-10.46; p=0.002). Intravenous rt-PA usage was 26% (29% telemedicine, 24% telephone; OR 1.27; 95% CI 0.71-2.25; p=0.41). Ninety-day outcomes were not different for Barthel Index, modified Rankin Scale, or mortality. There was no difference in post-thrombolysis intracranial hemorrhage (8% telemedicine, 6% telephone; p>0.999). Conclusions: This pooled analysis supports the hypothesis that stroke telemedicine consultations, compared with telephone-only, result in more accurate decision-making. Together with high rt-PA utilization rate, low post-rt-PA intracranial hemorrhage rate, and acceptable patient outcome, the results confirm that telemedicine is a viable consultative tool for acute stroke. The replication of the hub and spoke network infrastructure supports the generalizability of telemedicine when used in broader settings.

AB - Background and Purpose: Telemedicine can disseminate vascular neurology expertise and optimize recombinant tissue plasminogen activator (rt-PA) use for acute ischemic stroke in rural underserved communities. The purpose of this study was to prospectively assess whether telemedicine or telephone was superior for decision-making. Methods: The study design is a pooled analysis of two identically designed randomized controlled trials conducted in a multistate hub and spoke telestroke network setting with acute stroke syndrome patients, comparing telemedicine versus telephone-only consultations. From each trial, common data elements were pooled to assess, principally, for correctness of thrombolysis decision-making. Secondary outcomes included rt-PA use rate, 90-day functional outcome, post-thrombolysis intracranial hemorrhage, and data completeness. Results: Two hundred seventy-six pooled patients were evaluated. Correct thrombolysis eligibility decisions were made more often with telemedicine (96% telemedicine, 83% telephone; odds ratio [OR] 4.2; 95% confidence interval [CI] 1.69-10.46; p=0.002). Intravenous rt-PA usage was 26% (29% telemedicine, 24% telephone; OR 1.27; 95% CI 0.71-2.25; p=0.41). Ninety-day outcomes were not different for Barthel Index, modified Rankin Scale, or mortality. There was no difference in post-thrombolysis intracranial hemorrhage (8% telemedicine, 6% telephone; p>0.999). Conclusions: This pooled analysis supports the hypothesis that stroke telemedicine consultations, compared with telephone-only, result in more accurate decision-making. Together with high rt-PA utilization rate, low post-rt-PA intracranial hemorrhage rate, and acceptable patient outcome, the results confirm that telemedicine is a viable consultative tool for acute stroke. The replication of the hub and spoke network infrastructure supports the generalizability of telemedicine when used in broader settings.

KW - randomized controlled trials

KW - rural health

KW - rural hospitals

KW - stroke

KW - telemedicine

KW - telestroke

KW - tissue plasminogen activator

UR - http://www.scopus.com/inward/record.url?scp=84859528967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859528967&partnerID=8YFLogxK

U2 - 10.1089/tmj.2011.0116

DO - 10.1089/tmj.2011.0116

M3 - Article

C2 - 22400970

AN - SCOPUS:84859528967

VL - 18

SP - 230

EP - 237

JO - Telemedicine Journal and e-Health

JF - Telemedicine Journal and e-Health

SN - 1530-5627

IS - 3

ER -